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Background: Infectious Pancreatic Necrosis (IPN) is a highly contagious birnavirus disease of farmed salmonid fish,
which often causes high levels of morbidity and mortality. A large host genetic component to resistance has been
previously described for Atlantic salmon (Salmo salar L.), which mediates high mortality rates in some families and
zero mortality in others. However, the molecular and immunological basis for this resistance is not yet fully known.
This manuscript describes a global comparison of the gene expression profiles of resistant and susceptible Atlantic
salmon fry following challenge with the IPN virus.
Results: Salmon fry from two IPNV-resistant and two IPNV-susceptible full sibling families were challenged with the
virus and sampled at 1 day, 7 days and 20 days post-challenge. Significant viral titre was observed in both resistant
and susceptible fish at all timepoints, although generally at higher levels in susceptible fish. Gene expression profiles
combined with gene ontology and pathway analyses demonstrated that while a clear immune response was observed
in both resistant and susceptible fish, there were striking differences between the two phenotypes. The susceptible fish
showed marked up-regulation of genes related to cytokine activity and inflammatory response that evidently failed to
protect against the virus. In contrast, the resistant fish demonstrated a less pronounced immune response including
up-regulation of genes relating to the M2 macrophage system.
Conclusions: While only the susceptible phenotype shows appreciable mortality levels, both resistant and susceptible
fish can become infected with IPNV. Susceptible fish are characterized by a much larger, yet ineffective, immune
response, largely related to cytokine and inflammatory systems. Resistant fish demonstrate a more moderate, putative
macrophage-mediated inflammatory response, which may contribute to their survival.
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Infectious pancreatic necrosis virus (IPNV) is a pathogen
of salmonid fish which can cause high mortality and
morbidity of cultured Atlantic salmon (Salmo salar L.)
and rainbow trout (Oncorhynchus mykiss) and is respon-
sible for serious economic losses to the aquaculture in-
dustry. IPNV forms part of the genus Aquabirnavirus
and is a member of the Birnaviridae family, characterized
by a bi-segmented double-stranded RNA genome. The
clinical symptoms of IPNV infection include a swollen
abdomen or eyes, darkening of the skin, pancreas necro-
sis and spiral swimming and the disease may eventually
result in the death of infected hosts. In Atlantic salmon,
outbreaks of the disease typically occur in two distinct
windows of the production cycle; as newly-hatched fry
at first feeding and in post-smolts during the months
following transfer to seawater [1]. Vaccination can be
used to protect post-smolt fish [2], but the control of
freshwater outbreaks is dependent upon biosecurity in
hatcheries and the level of innate resistance of the sal-
mon fry. In this freshwater fry phase of the salmon life
cycle, IPN outbreaks can result in near-complete popula-
tion losses [1].
There is a large and significant host genetic compo-
nent to variation in IPN mortality levels at both stages
of the salmon lifecycle [3–5]. In addition, a quantitative
trait locus (QTL) was demonstrated to have a major ef-
fect on IPN mortality in the seawater environment [6],
and this QTL was subsequently confirmed in freshwater
and seawater in both Scottish [7–9] and Norwegian [10,
11] populations. This major QTL results in a marked
difference in mortality level (up to 100 %) between
homozygous susceptible and homozygous resistant fish
within and across families, with evidence for partial
dominance of the resistance allele [8, 11]. As a result of
the substantial genetic variation in host resistance, se-
lective breeding for IPNV resistance has been effective
in commercial aquaculture populations through both
family and marker-based selection [5, 8, 10, 11]. Re-
cently, Moen et al. [11] discovered SNPs associated with
the putative QTL genotype (r2 0.57 – 0.58) in the
cadherin-1 gene (CDH1) gene which encodes a protein
that co-locates with the IPN virus in liver cells and can
bind to the IPN virus in vitro. These results suggest a
possible role for CDH1 in the entry of the virus to host
cells and that a non-synonymous SNP in the CDH1 gene
may form part of the underlying mechanism of the QTL.
The host response to IPNV infection has been studied
in salmonid fish and associated cell lines, and markers of
type I and type II interferon responses are typically ob-
served [12–15]. Further, Skjesol et al. [16] studied the
host response to IPNV isolates of high and low virulence
and demonstrated that both mortality levels and expres-
sion of key host immune response genes were positivelyassociated with viral replication. Recent studies have also
examined the differential gene expression response to
infection between (partially) resistant and susceptible
fish. For example, Cofre et al. [17] demonstrated that the
expression of several pro-inflammatory genes and tran-
scription factors was significantly higher in the head kid-
ney of resistant fish. Most recently, Reyes-López et al.
[18] studied head kidney gene expression profiles of
resistant and susceptible salmon fry full-sibling families
and suggested that a limited and prolonged immune re-
sponse is associated with resistance while an acute short
response is characteristic of susceptible fish.
In the current study, a series of IPNV challenges and
microarray interrogations was undertaken to examine and
contrast the transcriptome profile of IPNV-challenged
whole fry from two IPN-susceptible families and two
IPN-resistant families at 1 day, 7 days and 20 days
post-challenge. Family- and timepoint-matched mock-
challenged control fish were used as a baseline for
comparison. An understanding of the differences in
host response between resistant and susceptible geno-
types is critical to advancing our understanding of the
functional basis of genetic resistance to IPNV in sal-
mon, and providing a more general perspective on the
question of how host resistance can act to ameliorate
viral pathogenesis.
Results
Disease challenge experiments
To evaluate the difference in gene expression profiles
between resistant and susceptible salmon fry, a subset of
the most susceptible (n = 2) and the most resistant
families (n = 2) from a previous study were examined.
These families were selected based on an earlier IPNV
immersion challenge experiment described by Houston
et al. [8]. The family-specific mortality levels (averaged
across the two replicate challenge tanks) are shown in
Fig. 1. Families J and N were chosen as the ‘genetically sus-
ceptible’ families (mean mortality 33 %) and families Q
and T were chosen as the ‘genetically resistant’ families
(mean mortality 0 %). IPNV immersion challenges for the
gene expression study commenced immediately after these
initial challenge experiments, using full siblings of the fry
used in the mortality study. Full details of the challenge
protocol are given below in ‘Methods’.
Family comparison
For each family, six replicate tanks were challenged with
IPNV alongside six control, mock-challenged tanks (two
challenge tanks and two control tanks per timepoint,
n = 50 per tank). At 1 day, 7 days and 20 days post-
IPNV-challenge, the tanks were terminated and all
surviving fry were sampled for RNA extraction and
subsequent transcriptomics. The mortality profiles of
Fig. 1 Family cumulative mortality. Cumulative mortality for the twenty families challenged with IPNV in the experiment described in [8]. The
values are the mean of two replicate tanks. For the purposes of the subsequent gene expression challenge experiments on full siblings of these
fish, families J and N were designated susceptible, and families Q and T resistant
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challenge experiment on their full siblings; i.e., fam-
ilies J and N showed significant mortality while fam-
ilies Q and T did not. As expected, there was also
negligible mortality in the mock challenged tanks
(Fig. 2). Note that these experiments were stopped at
20 days post infection; hence susceptible families do
not reach the previously observed mortalities over
30 %, but the expected difference in mortality profile
between the resistant and susceptible families is still
observed (Fig. 2).
IPNV virology
Real-time PCR results revealed the presence of IPNV in
both challenged resistant and susceptible families at all
timepoints post infection (Fig. 3). Viral load was higher
on average in susceptible fish than resistant fish at 7 and
20 days post infection (dpi) (104 vs 105 IPNV particles
per ng of total RNA). Viral load was lower at 20 dpi than
7 dpi for susceptible fish, which might be explained by
the mortality observed in these families from around 10
dpi, which is likely to have resulted in removal of fish
with the highest viral load. These results demonstrate
that animals with disparate genetic resistance can become
infected and that viral infection and replication occurs in
resistant genotypes, implying that genetic resistance can-
not be entirely due to an inability of the virus to enter the
cells of the host.
Microarray profiling of gene expression
A broad-level gene expression comparison of genetically
resistant and susceptible families at 1 dpi, 7 dpi and 20dpi was performed using microarrays (Additional file 1).
RNA extracted from whole fry homogenates were pooled
in four biological replicates (four fry per replicate) per infec-
tion status (IPNV-challenged or control) per timepoint per
family were used for microarray hybridization. In all cases,
the gene expression values of IPNV-challenged samples at
each timepoint and genotype were compared to matched
controls (such that ‘up-regulation’ refers to a significantly
higher gene expression signal in IPNV-challenged fish).
Initial analysis showed no indication of systematic bias
due to tank effect or day of hybridization. A striking
pattern of global gene expression differences between
the families was evident, in particular at 7 and 20 days
post-challenge, when compared to timepoint and family-
matched controls (Fig. 4). The susceptible families showed
substantially higher numbers of both up-regulated and
down-regulated transcripts than resistant families, and an
abundance of transcripts with notably large up-regulation
which was not observed in resistant families (Fig. 4). At 1
dpi, the global profile of transcriptional response was simi-
lar in terms of magnitude and number of differentially-
expressed transcripts, albeit with little overlap in terms of
specific differentially expressed transcripts.
Clustering of gene expression profiles for each time-
point and genotype demonstrated that the susceptible 7
and 20 dpi samples clustered separately from the other
genotype x timepoint combinations (Fig. 5). The abun-
dance of highly up-regulated genes is evident from the
bias towards red and orange colours for susceptible fish
at 7 and 20 dpi which is not observed for other condi-
tions (Fig. 5), consistent with the volcano plots (Fig. 4).
The gene expression profile of resistant fish at 7 and 20
Fig. 2 Mortalities for the four selected families. Cumulative mortality levels (average across two replicate tanks) in the four families from the tanks
terminated at 20 days post-challenge in the current study. The control value is averaged across all families
Fig. 3 IPNV viral load in resistant and susceptible families. Mean and
standard error log10 IPNV copy number per ng total RNA for resistant
and susceptible samples at 1, 7 and 20 days post infection. Significance
symbols correspond to the p-values for Mann–Whitney U test between
resistant and susceptible samples (* p≤ 0.05; ** p≤ 0.01; *** p≤ 0.001;
**** p≤ 0.0001)
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resistant and susceptible), which is consistent with a
more moderate immune response. Despite this, some
resistant-specific sets of differentially expressed genes
were observed, which revealed that the differences in the
genetic immune response between resistant and suscep-
tible fish are not only quantitative, but also qualitative.
The identified set of resistance-specific genes may pro-
vide candidates allowing for improved understanding of
the functional differences between IPNV-resistant and
IPNV-susceptible fish, and of how transcriptomic re-
sponse determines the outcome of an infection.
Enrichment analysis
To examine the observed expression patterns in more
detail, GO enrichment analyses were conducted for sig-
nificantly up- and down-regulated transcripts for each
comparison (Additional file 2). Among the GO terms
enriched in the up-regulated transcripts, the term “im-
mune response” was (unsurprisingly) clearly enriched in
susceptible fish both at 7 dpi and 20 dpi (76 and 95
genes, respectively), while in resistant fish it was only
enriched at 20 dpi and with a much lower number of
genes (32) (Fig. 6). This pattern is consistent with a
heightened immune response in susceptible fish. Further,
Fig. 4 Volcano plots of global gene expression response in resistant and susceptible families following IPNV challenge. Volcano plots of the log2
fold change vs. log10 p-value of every transcript for each of the six comparisons are shown. Transcripts with p values < 0.05 (significant) are
shown in red, while those with p values > 0.05 are shown in blue. The number of significant down-regulated (blue) and up-regulated (red)
transcripts for each comparison are shown in the corners of each volcano plot. Likewise, the number of common down-regulated and up-regulated
genes between each comparison are shown in the space between their volcano plots
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up-regulated immune-related GO terms which pointed
towards a large number of cytokines and other genes in-
volved in inflammation and apoptosis being differentially
expressed in susceptible fish but not in those from re-
sistant families (Fig. 6). Similarly, “ubiquitin-dependent
degradation” shows a similar pattern and therefore may
also play a role in immune defence against IPNV or its
dysregulation (Fig. 6). Among the down-regulated genes,
many enriched GO terms both in resistant and susceptible
families were related to metabolism (e.g., “lipid biosyn-
thetic process”, “tRNA metabolic process” or “tetrapyrrole
metabolic process”), which may be related to lower energy
availability as an effect of anorexia, one of the symptoms
of IPN. A larger number of metabolism GO terms (“glyco-
protein metabolic process”, “vitamin metabolic process”
or “energy reserve metabolic process) were enriched for
differential expression in susceptible individuals, which
is consistent with a more severe viraemia. In addition,
many terms related to muscle activity were observed
only in susceptible individuals at 20 dpi (e.g., “myofibril”,
“regulation of muscle contraction” or “muscle myosin
complex”), which may explain the abnormal swimming
patterns seen in affected fish, another symptom of the
disease.A supplemental enrichment analysis was performed
using the KEGG pathway database (Additional file 3).
This yielded findings that were consistent with those of
the GO enrichment analysis, with several generic viral
pathways (e.g., “Measles”, “Influenza A” or “Epstein-Barr
virus infection”) and the immune pathway “Toll-like re-
ceptor signaling pathway” up-regulated at 7 and 20 dpi
in both susceptible and resistant fish, albeit always more
intensely in the former. In addition, several up-regulated
pathways relating to immune response were observed to
be enriched at 7 and 20 dpi in susceptible samples but
only at 20 dpi in resistant samples (i.e., “TNF signalling
pathway, “cytokine-cytokine receptor interaction” or
“chemokine signalling pathway”). Among these were
the “RIG-I like receptor signaling" pathway, responsible
for detecting viral particles and activating the interferon
response; and the “Jak-STAT signaling" pathway, respon-
sible for activating interferon stimulated genes (ISGs). This
clearly points towards involvement of interferon response
pathways in both susceptible and resistant families, albeit
to a greater extent in susceptible fish. In contrast, the
coagulation and complement pathway was found to be
consistently down-regulated only in susceptible families
later in the course of infection (at 20 dpi; Additional file 4).
The down-regulation of this pathway may be related to
Fig. 5 Heatmap of differentially expressed genes in resistant and susceptible families. Heatmap showing the expression of all the differentially
expressed genes with log2 fold change > 1 in any of the six comparisons and the clustering of the susceptible and resistant samples at 1, 7 and
20 days post infection
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mechanisms. The fact that the specific and widespread
down-regulation of this pathway is unique to suscep-
tible fish at 20 dpi may warrant further investigation.
Interferons and resistance-associated genes
The interferon response pathway is considered the pri-
mary antiviral defence system both in fish and in other
vertebrates [19] and in particular has been shown to be
paramount in host response to IPNV [12–15]. There-
fore, the expression patterns of key interferons and ISGs(Fig. 7) were specifically examined. In susceptible fish,
the up-regulation of both interferon alpha (IFN-α) and
interferon gamma (IFN-γ) was clear at 7 dpi and remained
high at 20 dpi. Conversely, resistant fish showed up-
regulation of IFN-γ at 1 and 7 dpi, but not at 20 dpi, while
IFN-α remained at basal levels throughout the infection. As
expected, some of the most important ISGs, specifically
interferon inducible Mx protein (Mx), ISG15 ubiquitin-like
modifier (ISG15), viperin (vip-2), C-C motif chemokine 19
(CCL19) and interferon-inducible protein gig2 (gig2), were
also clearly up-regulated in susceptible samples, with log2
Fig. 6 Scatterplots of gene expression for selected enriched GO terms. Scatterplots showing the log2 fold change values of genes differentially
expressed at any of the six comparisons and annotated with the GO terms: a “immune response”, b “cytokine activation” and “inflammatory
response”, c “apoptotic process”, and d “ubiquitin-dependent protein catabolic process”
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regulation was also observed in the resistant fish at the
same timepoints but with log2 fold changes ~1–2×. Reyes
Lopez et al. [18] also observed a more moderate interferon
alpha response in head kidney of resistant fish but, in con-
trast to the current study, this was only observed at 1 dpi
and not by 5 dpi.
To resolve additional details of the basis for the differen-
tiated immune response between phenotypes, the expres-
sion profile of some individual transcripts, up-regulated in
resistant but not in susceptible samples were specifically
examined (Fig. 7). Several of these transcripts have obvi-
ous immune functions, like interferon regulatory factors 3
and 8 (IRF3 and IRF8), interleukin 3 receptor (IL3r) or
macrophage colony-stimulating factor (M-CSF); while
other transcripts, although less well-known, are also
connected to the immune system: F-box only protein 9
(FBXO9) and Transcription factor 3 or Transcription
factor E2-alpha (TCF3). All these genes showed higher
expression in resistant fish at 1 dpi except IRF3, whichhad higher expression at both 7 and 20 dpi. These genes
are functionally connected to myeloid cell lineages and
macrophages, which are important components of the
cellular immune response.Discussion
Resistant and susceptible Atlantic salmon families were
identified in order to allow experimental study of the
transcriptomic aetiology of heritable resistance to IPN.
The existence of a major genetic component to Atlantic
salmon resistance to IPN has been extensively docu-
mented previously [3–11]. The functional basis of gen-
etic resistance to IPN in salmon has been less studied
but is equally important, since it can shed light on the
biological mechanisms underlying the genetic resistance
and susceptibility. Knowledge of these mechanisms can
help understand viral infection processes more generally
and improve opportunities for minimizing the potential
for impact of viral epizootics in fish.
Fig. 7 Expression profiles for selected key interferon-related and resistance-specific genes. Log2 fold change values for selected genes in susceptible
and resistant families at 1, 7 and 20 days post infection. Genes of interest were selected based on their relationship with the interferon pathway
(left of figure) or due to their specific up-regulation in resistant samples (right of figure)
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The resistant families in this experiment displayed virtu-
ally no losses and may thus be considered completely re-
sistant to mortality as a consequence of IPN. Given that
the genetic resistance is almost monogenic [6, 10], the
lack of mortality could reflect a matching absence of
viral infection following challenge, for example due to
the failure of the virus to attach, internalize or replicate
in host cells. Indeed, Moen et al. [11] suggest that failure
to enter host cells is the primary mechanism underlying
the major QTL controlling resistance. However, in the
current study, the estimated IPN virus copy number in
IPN-resistant salmon strongly imply successful viral rep-
lication within host cells. While the underlying QTL
genotype of the parents of the resistant families were not
known, they were postulated to be homozygous for the
resistance allele (‘RR’) [8], and virology results from con-
firmed ‘RR’ homozygous fish within QTL-segregating
families show similar estimated IPNV copy number profiles
(unpublished data). A possible reason for the discrepancybetween studies is that Moen et al. [11] only described data
from sampling the livers of resistant fish at 34 days post-
infection, by which stage it is conceivable that the resistant
fish had cleared the infection, or the virus may be replicat-
ing in other tissues. Reyes-Lopez et al. [18] also reported
that both resistant and susceptible fry were infected with
IPNV at 1 and 5 dpi, but with higher titres observed in
susceptible fish, consistent with the current study. Further,
in the current study and in previous transcriptional com-
parisons between fry showing different IPN resistance phe-
notypes [17, 18], stimulation of the immune system in
response to the virus was reported for both susceptible and
resistant samples. Therefore, it is likely that a component of
genetic resistance to IPNV is due to differential response of
the fish to the virus once they are infected. Indeed, this
differential immune response may be connected to host
genetic variation impacting on virus attachment, internal-
ization or replication whereby delay in these processes in
resistant fish gives the immune system an opportunity to
successfully respond to the infection.
Robledo et al. BMC Genomics  (2016) 17:279 Page 9 of 16Immune response in susceptible and resistant fish
The observed immune response to IPNV is generally lar-
ger and more intense in susceptible fish at 7 and 20 dpi,
involving almost every major component of the innate
immune system. Resistant fish also showed an immune
response to IPNV at both 7 and 20 dpi, but lower in
both number of differentially expressed genes and in
their intensity of expression. These results are, in part,
consistent with those observed by Reyes-López et al.
[18], where a high inflammatory response was observed
in susceptible but not in resistant fish. However, Reyes-
López et al. [18] reported that the initial response at 1
dpi was more intense in susceptible fish but dropped to
near basal levels at 5 dpi, with lower values than resist-
ant fish for many immune-related genes. In the current
study, the differences between resistant and susceptible
genotypes were most marked at 7 days post-infection,
and the vast majority of innate immune response genes
had higher expression in susceptible fish. In addition,
despite using similar timepoints to the current study
for sampling, Cofre et al. [17] showed that for eight
immune-related genes, including IFN-α and Mx, expres-
sion levels were either equal or higher in resistant fish.
The differences may be due to the different samples used,
with liver or head kidney being examined in previous
studies and whole fry examined in the current study. An-
other potential reason for the differences between studies
could be the criteria used to define susceptible and re-
sistant families. The resistant families in the previously
published experiments had mortality rates between 15
and 30 % [17, 18], while in our experiment mortality of
resistant families was virtually zero, similar to baseline
controls. Hence, it may be possible that there are fun-
damental differences in the response to the IPN virus
in families that are fully (current study) or partially
(previous studies) resistant. However, it should be noted
that mortality level for any given genotype is related to a
number of factors including dose response [20], virulence
of the viral isolate employed for the challenge and a range
of factors relating to previous host history and environ-
ment such that even subtle differences in the dynamics of
the infection might impact observed mortality.
The inability of susceptible fish to stop the infection
seems to produce a disproportionate immune response
which includes high representation and expression of in-
flammatory pathway members, IFN-responsive elements
and cytokines leading to eventual apoptosis, with a more
controlled immune response being characteristic of resist-
ant fish. In Atlantic salmon challenged with infectious
salmon anaemia virus (ISAV), a dramatic up-regulation
of transcripts relating to innate immunity was observed
in susceptible individuals, which did not provide pro-
tection, while resistant individuals were characterized
by lower inflammatory response, which allowed fish tosurvive for longer periods under high viral loads until
the activation of pathways associated with adaptive im-
munity was able to clear the virus [21]. Similarly, bac-
terial infection by Piscirickettsia salmonis in susceptible
Atlantic salmon triggered an exacerbated but inefficient
immunological response [22]. While inflammation is
critical to the efficiency of the innate immune response
[23], long-term activation of inflammatory processes
can be seriously detrimental to the host [24]. The main
site of entry and early replication for IPNV is considered
to be the intestinal epithelium [25]. One of the symptoms
of IPNV infection in salmon is catarrhal enteritis, and last-
ing inflammation can produce damage in the intestinal
epithelium, as previously suggested for salmon and other
species [22, 26–28]. It is possible that a local and effective
immune response may be observed in the intestinal
epithelium of resistant fish, whereas susceptible fish fail
to control the virus at this early stage and it becomes a
more systemic infection. Further, intestinal damage and
anorexia, causing lower energy availability, may partially
explain the down-regulation of metabolic pathways and
processes. In a previous study in Atlantic salmon with
different levels of flesh n-3 long-chain polyunsaturated
fatty acid, a connection between high lipid levels and
anti-inflammatory action was suggested [29]. Hence,
the down-regulation of lipid metabolism in susceptible
fish might contribute to the exacerbation of the im-
mune response. In the current study, the use of whole
fry as the sample ensured all tissues were included in
the comparison, but obviously has the limitation of pre-
cluding the identification of localized and tissue-specific
responses and potentially obscuring levels of response.
There was marked and almost universal down-regulation
of the complement and coagulation cascade observed in
susceptible fish at 20 dpi (but not other timepoints). The
complement system plays a major role in viral pathogen-
esis, including the modulation of both inflammatory and
adaptive immune responses [30] and contributes to neutral-
isation of certain viruses in salmonid fish [31]. There is
clear evidence for viral evasion of the host complement
system in a wide range of host-pathogen relationships,
often including the usurping of host complement regulators
by viral homologues, thus highlighting its importance in
host response [30]. VHSV infection in rainbow trout, for in-
stance, produces a clear down-regulation of complement
genes [32], which might suggest a role for active viral
suppression of this pathway. In humans, the complement
system is suppressed in individuals persistently infected
with hepatitis C and virus-mediated down regulation of
the complement system is pertinent to this persistence.
Given the fact that susceptible fish which survive up to
20 days have a higher chance of longer-term survival since
the most susceptible individuals have already died, and
that salmon are known to exhibit an IPNV carrier-state
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acteristic of IPNV carriers among susceptible fish.
Transcripts related to ubiquitin-mediated protein deg-
radation were typically up-regulated in susceptible fish
but less so in resistant fish. The ubiquitin system plays a
critical role in immune defence, having a critical role in
antigen presentation [34] and being used as part of the
host defence strategy to suppress viral production [35].
In the case of IPNV, manipulation of protein metabolism
of the host cell is postulated to be a key viral strategy in
evading the interferon-mediated host response [36], and
the ubiquitin-proteosome system is likely to contribute
to this protein turnover.
Interferon
The interferon system plays a critical role in both innate
and adaptive responses to virus infection. In the current
study, a clear up-regulation of genes and pathways asso-
ciated with the interferon response was observed, both
in resistant and susceptible fish, but with this being
much more pronounced in the latter. Interferon produc-
tion and its downstream consequences in the innate im-
mune system are the primary host defence mechanisms
against IPNV and other viruses in salmonid fish [13, 31].
ISGs like Mx, ISG15, Vip-2, gig2 or CCL19, all of which
were up-regulated in the current study, are among the
most well-established IFN-induced genes displaying anti-
viral properties, and have previously been shown to play
a role in host responses to IPNV infection in salmon
[12, 18, 37–41]. Mx proteins, previously reported to block
IPNV replication in Atlantic salmon cell culture [42], were
found to be up-regulated in kidney, liver, spleen and gills
of Atlantic salmon challenged with IPNV [43]. In addition,
Cofre et al. [17] detected higher expression of Mx in the
head kidney of resistant compared to susceptible fish at 1
dpi and of Vig-2 at 1 and 5 dpi, while IFN-α expression
was higher in resistant samples at every time point (1, 5
and 21 dpi). Reyes-López et al. [18] detected higher ex-
pression of CCL19 in susceptible fish at 1 dpi but this
dropped back to basal levels by 5 dpi. Interestingly
however, its expression in resistant samples remained
moderately up-regulated both at 1 and 5 dpi. This ex-
pression pattern was consistent with the expression of
IFN-α, which showed a similar profile to CCL19 [18].
Conversely, in the current study, these genes did not
show any response at 1 dpi, yet were moderately up-
regulated in resistant fish (logFC ~ 2) at 7 and 20 dpi,
but highly up-regulated in susceptible (logFC ~4) fish.
This suggests that this system alone is unlikely to be able
to provide a sufficiently effective response to infection.
A number of IFN-related genes were up-regulated
specifically in resistant fish at certain timepoints. For
instance, IFN-γ showed higher expression at 1 dpi in
resistant fish but not in susceptible fish (Fig. 7).Although the difference was small, it could be biologic-
ally relevant, especially considering that IRF8, which
was previously shown to respond specifically to IFN-γ
in Atlantic salmon [37], was also only up-regulated in re-
sistant fish at 1dpi. It is also worth noting that in resistant
fish IFN-α does not seem to be up-regulated at 7 dpi and
scarcely at 20 dpi, unlike the case for susceptible fish.
Although IFN-γ is a much weaker inducer of ISGs than
IFN-α [44], interferon-independent activation of ISGs
has been reported in mammals involving IRF3 [45],
[46], and this gene, which is only up-regulated in resist-
ant fish at 7 and 20 dpi, has been shown to activate the
expression of ISGs in fish [47]. Therefore, perhaps a
different IFN-activation route during the early response
to IPN infection leads to altered downstream responses
and disease outcome. Furthermore, in mammals, INF- γ,
also stimulates the host defence by enhancing the function
of the proteasome and antigen presentation [48]. Hence it
is possible that early up-regulation of IFN-γ in resistant
fish may contribute to virus control through an increase
in effectiveness of the host ubiquitin-proteosome function
and/or by improving the resistance of this pathway to ma-
nipulation by the virus. However, while IFN-γ showed po-
tent antiviral activity against salmonid alphavirus 3 (SAV3)
in vitro, its antiviral activity against IPNV was found to be
lower than that of IFN-α [37]; hence the importance of
the two types of interferons in the immune response to
IPNV remains unclear.
Macrophages may be important in defining IPN
resistance
IFN-γ is also instrumental in promoting T helper cell re-
sponse and activating macrophages [49], which show the
highest basal expression of the IFN-γ receptor of all cell-
types in rainbow trout and zebrafish [50]. Rainbow trout
macrophages treated with IFN-γ exhibit an increase in
Major Histocompatibility Complex I and II expression,
suggesting an important role in enhancing antigen
presentation [51–54]. Macrophages show a variety of
immunity-related functions, ranging from production
of pro-inflammatory or anti-inflammatory cytokines, to
phagocytosis and degradation of pathogens and may
also be involved in stimulation of the adaptive immune
system [55, 56]. IPNV is known to replicate in macro-
phages of Atlantic salmon [57] and infection is known
to stimulate macrophage interferon production [58].
Hence, macrophages may play key roles in the outcome
of IPNV infection and this hypothesis is supported by
observation of up-regulation of several genes related to
macrophage function specifically in resistant families.
Macrophage colony stimulating factor (M-CSF) was
up-regulated in the resistant but not susceptible fam-
ilies at 1 dpi, and is the principal regulator of survival,
proliferation, and differentiation of macrophages and
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macrophage pro-inflammatory cytokine activity [63],
while IL3r and IRF8 are involved in myeloid cell differ-
entiation [64] and maturation [65] respectively. Also
FBXO9, which was upregulated in resistant fish at 1 dpi, is
a substrate recognition component of a (SKP1-CUL1-Fbox)
E3 ubiquitin-protein ligase component which mediates
ubiquitination and subsequent proteosomal degradation,
blocked the production the pro-inflammatory cytokine Il-
6 in mouse macrophages [66].
Macrophages can be activated through a number of
different pathways. While the classical M1 pathway leads
to a typical inflammatory phenotype, the alternative acti-
vation pathway M2 is involved in tissue repair [67]. M2
macrophage activation was shown to be enhanced by the
M-CSF [68] which was upregulated in resistant fish in
the current study, and IRF3 (up-regulated in resistant
fish at 7 and 20 dpi) is known to be diminished in M1-
like macrophages and enabled in M2-like macrophages
[69]. In contrast, IRF8, up-regulated in susceptible fish
at the same timepoints, is characteristic of an M1-like
macrophage response [69]. Therefore, M2-type macro-
phages, and their balance with M1 macrophages, might
be involved in the successful immune response of IPNV-
resistant Atlantic salmon. Atlantic salmon macrophage
activity has been previously reported to increase after
ISAV and salmon pancreas disease (SPD) viral infections
[70, 71], while a monocyte-macrophage specific gene ex-
pression was higher in Piscirickettsia salmonis resistant
fish than in susceptible fish [22]. The M2 "repair" desig-
nation broadly refers to macrophages that function in
constructive processes like wound healing and tissue re-
pair, and those that turn off damaging immune system
activation by producing anti-inflammatory cytokines.
Teleost macrophages were shown to down-regulate in-
flammatory responses following exposure to apoptotic
cells [72]. It is therefore conceivable that the M2 macro-
phage response may result in better tuning of the immune
response in resistant samples, keeping inflammation and
apoptosis at appropriate levels and perhaps limiting virus
spread by inhibiting their escape from cells. Although the
rapid innate immune system may generally be more effect-
ive in protecting against RNA viruses [17], it is possible
that extending survival of fish until the adaptive immune
system can clear the IPN virus, is more important in the
present case than a stronger initial innate reaction that
could be detrimental to the host. In fact, a lower inflam-
matory response, combined with an adaptive T-cell re-
sponse, was suggested to be responsible for survival and
ISAV clearance in a challenge test in Atlantic salmon [21].
Conclusions
IPN resistant and susceptible families were challenged
with IPNV to study the differences in their gene expressionprofiles. While only the susceptible families suffered appre-
ciable mortality, both phenotypes showed significant viral
load; hence resistance is apparently not entirely due to the
inability of IPN to infect the fish, which is confirmed by the
observed immune response in the resistant families.
The susceptible fish are characterized by a much larger,
yet ineffective, immune response, which involved the
production of interferons and other cytokines, and pro-
voked exacerbated inflammation and apoptosis. Resist-
ant fish demonstrated a more moderate response and
their gene expression profile pointed to a role of the
M2-macrophage system in modulating the inflammatory
response, which may contribute to their survival, and par-
tially explain the marked differences between the immune
responses of susceptible and resistant families.
Methods
Families and IPNV challenge experiment
In order to compare the transcriptomic responses of re-
sistant and susceptible fry families to IPNV challenge,
the phenotypes of the families were first defined accord-
ing to a challenge experiment performed on twenty full
sibling families showing diverse IPN resistance breeding
values, as calculated using seawater ‘field trial’ data, from
the Scottish breeding nucleus of Landcatch Natural Se-
lection Ltd. The details of this first genetics experiment,
including the rearing conditions of the fish and the
method of IPNV preparation, are given in [8]. Briefly,
IPNV isolate V0512-1 [serotype A2 (Sp)] was prepared
and harvested using low passage number (P2) in RTG-2
cells. Three replicates of ~ 100 fry from each of the
twenty families were transferred to separate 15 L aerated
challenge tanks (60 tanks in total) approximately 60 days
post hatching. A consistent immersion IPNV challenge
(challenge dose ~5.0 x 105 TCID 50 mL−1) was applied
to two of the three replicates from each family, with the
other tank from each family sham-challenged (two chal-
lenge and one control tank). The IPNV infection in each
tank was then allowed to progress without intervention
until there were fewer than three mortalities per day
(summed across all of the tanks) for three consecutive
days [8].
For the gene expression studies, four families with
highest (J & N), and lowest (Q & T) mortality were
chosen. The rearing conditions of the fish and method
of virus preparation are given in Houston et al. 2010 [8].
Twelve replicates of 50 fry (~95 days post-hatching,
mean weight 0.6 g) from each family were transferred
from the 15 l holding tanks to 5 l challenge tanks (48
tanks total) maintained at ~ 10 °C. Six of these replicate
tanks per family were IPNV-challenged and the remaining
six tanks were mock-challenged. The challenge protocol,
conditions and monitoring procedure for this experiment
were as previously described [8]. However, three timepoints
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fry from IPNV challenged and control tanks for subsequent
RNA and DNA extraction. These timepoints were in-
formed from the previous challenge experiment and were
chosen at 1 day post-challenge (early timepoint), 7 days
post-challenge (around the time of the first mortalities) and
20 days post-challenge (around peak daily mortality level).
At each of the three timepoints, two IPNV-infected and
two control tanks for each family were terminated, with all
surviving fish euthanized and then snap frozen in liquid ni-
trogen and stored at −80 °C until further use. Fish were
euthanised using a non-schedule 1 method under a proced-
ure specifically listed on the appropriate Home Office (UK)
license and all experiments were performed under approval
of Cefas ethical review committee and complied with the
Animals Scientific Procedures Act. Mortalities that oc-
curred prior to tank termination were removed and frozen
for future IPNV testing.
IPNV testing
Fry mortalities and survivors from the challenged tanks
and control tanks were tested for the presence of IPNV
using different methods. Fry were weighed, homogenised
using sterile pestle, mortar and sand then diluted 1:10 in
cellculture medium. The homogenate was centrifuged at
2500 × g for 15 min. at 4 °C then the supernatant re-
moved and filtered through 0.45 μm filter (Whatman)
before inoculation onto 24 h old confluent monolayers
of CHSE-214 cells in 96-well cell culture trays for titra-
tion according to [73]. Culture trays were incubated at
15 °C and titres read after 7 days. Wells showing positive
cytopathic effect (CPE) for each sample were further
tested by ELISA (Test-Line) to confirm the presence of
IPNV. Subsequently, for the determination of viral load
in the samples used for the microarray experiment, an
RT-QPCR assay applied in an accredited commercial la-
boratory (Integrin Advanced Biosystems, UK) was used.
Microarray platform
Microarray interrogations were performed using a custom-
designed, oligonucleotide microarray platform (Agilent)
with 44 K probes per slide (Salar_2; Agilent Design
ID:025520). This platform has been described in detail else-
where [74] and used in a number of subsequent studies
[29, 75–80], where the expected correlation between micro-
array fluorescence values and real-time PCR expression has
been established. The design is lodged with ArrayExpress
(http://www.ebi.ac.uk/arrayexpress) under accession num-
ber A-MEXP-2065. Dual-label hybridisations were under-
taken, with each experimental sample (Cy3 labelled) being
competitively hybridised against a pooled reference control
(Cy5 labelled) comprising equimolar amounts from
each experimental RNA sample. The interrogations
comprised 144 separate hybridisations; 2 genotypes(susceptible, resistant) × 2 families for each genotype ×
2 challenge states (control, challenged) × 3 timepoints
(1, 7, 20 dpi) × 4 biological replicates for resistant (2
from each of two tanks) and 8 biological replicates for
susceptible (4 from each of two tanks). All microarray
data has been deposited under accession E-MTAB-
4275 in ArrayExpress. A biological replicate comprised
four individual fry (see below). A preliminary analysis
suggested evidence for a segregating QTL in the sus-
ceptible families and therefore twice as many offspring
were screened. It was later established that the evi-
dence for a segregating QTL in these families was in-
conclusive and therefore comparisons were made at
the family level only. A direct comparison of QTL ge-
notypes within families has been conducted using a
combination of microarray and RNA-seq in other fam-
ilies, which will be reported separately. The analyses
took the unbalanced design into account.
RNA extraction and purification
From the −80 °C stored samples, 12 survivors from each
tank were randomly selected for microarray analysis.
Whole fry (n = 576) were homogenised in 8 volumes of
TRI Reagent (Sigma–Aldrich®, St. Louis, U.S.A.) using a
Polytron mechanical homogeniser (Kinematica PT 1300
D, Lucerne, Switzerland) and the RNA extracted follow-
ing the manufacturer’s instructions. RNA quantity and
quality were assessed by spectrophotometry (NanoDrop
ND-1000, Thermo Scientific, Wilmington, U.S.A.) and
agarose gel electrophoresis respectively. Equal amounts
of RNA from four individuals, sourced from the same
tank were pooled to form each biological replicate. The
RNA from each pool (n = 144) was column-purified
(RNeasy Mini Kit, Qiagen, Crawley, UK), and then re-
quantified and quality assessed as described above.
RNA amplification and labelling
Each pooled RNA sample was amplified (TargetAmpTM
1-Round Aminoallyl-aRNA Amplification Kit, Epicentre
Technologies Corporation, Madison, Wisconsin, USA)
according to the manufacturer’s instructions. Following
QC (Nanodrop quantification and agarose gel electro-
phoresis) a reference (pool) sample was created by com-
bining an equal amount of aRNA from each of the 144
reactions. Each aRNA sample was indirectly labelled
(Cy3) and purified, while a similar (Cy5) labeling was
undertaken for aliquots of the pooled reference sample.
Briefly, Cy dye suspensions (Cy3 and Cy5) were prepared
by adding 44 μL high purity dimethyl sulphoxide (Strata-
gene, Hogehilweg, The Netherlands) per tube of Cy dye
(PA23001 or PA25001; GE HealthCare, Little Chalfont,
Bucks, UK). Each aRNA (2.5 μg) was denatured at 70 °C
for 2 min in 10.5 μL water and then 3 μL 0.5 M
NaHCO3 pH8.5 and 1.5 μL Cy dye (Cy3 or Cy5) was
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for 1 h at 25 °C in the dark and the excess label was re-
moved by spin-column purification (Qiagen GE Health-
care). Dye incorporation and purity were assessed via
spectrophotometer (NanoDrop) and, following agarose
gel (1 %) electrophoresis, aliquots of the labelled aRNA
were also visualised on a fluorescent scanner (Typhoon
Trio, GE Healthcare).
Microarray hybridization and quality filtering
Hybridisation was performed over 6 days (24 hybridisa-
tions per day) using proprietary apparatus and solutions
(Agilent Technologies) as per manufacturer’s instruc-
tions. For each reaction, 825 ng Cy5 labelled reference
pool and 825 ng Cy3 labelled individual sample were
combined in 35 μL nuclease free water and then 20 μL
fragmentation master mix added (comprising 11 μL of
10X blocking agent, 2 μL 25x fragmentation buffer and
7 μL nuclease free water). The reactions were then incu-
bated at 60 °C in the dark for 30 mins, chilled on ice,
and mixed with 55 μL 2x GEx Hybridisation buffer (pre
heated to 37 °C). Following centrifugation (18000 × g for
1 min) the samples were kept on ice until loaded
(103 μL) in a semi randomised order onto the micro-
array slides. Similar numbers of samples from the differ-
ent states, treatments and families were distributed
across slides (n = 6) each day. Hybridisation was carried
out in a rotating oven (Agilent Technologies) at 65 °C,
10 rpm for 17 h.
Following hybridisation, slides were subject to a num-
ber of washing steps performed in Easy-DipTM slide
staining containers (Canemco Inc., Quebec, Canada).
First, each microarray and backing gasket were disas-
sembled in Agilent Wash Buffer 1 and microarray slides
were transferred to an Easy Dip Rack submerged in
Wash Buffer 1. Following 1 min. incubation at room
temperature (c. 20 °C) and 150 rpm (Stuart Orbital Incu-
bator), slides were briefly dipped into Wash Buffer 1
pre-heated to 31 °C, then placed into Wash Buffer 2
(31 °C) for 1 min at 150 rpm. Finally, the slides were
transferred to acetonitrile for 10 s. and then Agilent
Stabilization and Drying Solution for 30 s. The slides
were then air dried in the dark and scanned within
two hours.
Scanning was carried out at 5 μm resolution on an
Axon GenePix Pro scanner (Axon Instruments Inc.) at
40 % laser power. The “auto PMT” function was enabled
to adjust PMT for each channel such that less than
0.1 % of features were saturated and so that the mean in-
tensity ratio of Cy3:Cy5 signal was close to one. Agilent
Feature Extraction Software (v 9.5) was used to identify
features and extract background subtracted raw intensity
values that were then transferred to GeneSpring GX (v12)
software where the quality filtering and normalisationsteps took place. Intensity values ≤ 1 were adjusted to 1
and a Lowess normalisation undertaken. Stringent quality
filtering ensured that features that represented technical
controls, saturated probes, probe population outliers or
probes which were not significantly different from the
background were removed. This left 33,688 of the original
43,466 probes available for downstream analysis and a
two-way unbalanced ANOVA was performed in the Gene-
spring software (Agilent, CA, USA) to assess differential
expression. The data will be submitted to arrayexpress
prior to publication.
Enrichment analyses
Gene ontology (GO) enrichment analysis was performed
using BLAST2GO [81] and KEGG pathway enrichment
using KOBAS 2.0 [82], using the total microarray probes
as background. Enrichment probability values for BLAS-
T2GO and KOBAS analyses were adjusted for multiple
testing (FDR-corrected P-values < 0.05) to consider sig-
nificantly over-represented GO-terms and KEGG path-
ways within each list of differentially expressed genes.
Heatmap, scatterplots and gene fold change graphs were
created using R v.3.0.1 [83] and the R packages NMF
[84] and ggplot2 [85].
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